Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl)thiomethylene bisphosphonate, in the treatment of Paget's disease of bone
- 1 January 1988
- Vol. 9 (6), 349-354
- https://doi.org/10.1016/8756-3282(88)90115-9
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Clinical and biological effects of low doses of (3 amino‐1 hydroxypropylidene)‐1,1‐bisphosphonate (APD) in Paget's disease of boneEuropean Journal of Clinical Investigation, 1982
- Effect of diphosphonates on the synthesis of prostaglandins in cultured calvaria cellsCalcified Tissue International, 1981
- Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in ratsCalcified Tissue International, 1980
- Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma.Proceedings of the National Academy of Sciences, 1980
- EFFECTS OF DISODIUM DICHLOROMETHYLENE DIPHOSPHONATE ON PAGET'S DISEASE OF BONEThe Lancet, 1979
- TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- DIAGNOSTIC PROCEDURES IN DISORDERS OF CALCIUM METABOLISMClinical Endocrinology, 1978
- Sodium Etidronate in the Treatment of Paget's Disease of BoneAnnals of Internal Medicine, 1977
- Osteoclast ultrastructure in Paget’s diseaseCalcified Tissue International, 1976
- Nuclear Inclusions in Paget's Disease of BoneScience, 1976